Regulatory T-cell dynamics with abatacept treatment in rheumatoid arthritis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Regulatory T-cell dynamics with abatacept treatment in rheumatoid arthritis
Authors
Keywords
-
Journal
INTERNATIONAL REVIEWS OF IMMUNOLOGY
Volume -, Issue -, Pages 1-9
Publisher
Informa UK Limited
Online
2018-05-15
DOI
10.1080/08830185.2018.1465943
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety profile of biological therapies for treating rheumatoid arthritis
- (2017) Juan D. Cañete et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Immunopathogenesis of Rheumatoid Arthritis
- (2017) Gary S. Firestein et al. IMMUNITY
- Immune Mechanisms and Novel Targets in Rheumatoid Arthritis
- (2017) Swamy Venuturupalli IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA
- CTLA-4 blockade in the treatment of rheumatoid arthritis: an update
- (2016) Maurizio Cutolo et al. Expert Review of Clinical Immunology
- CD28 Costimulation: From Mechanism to Therapy
- (2016) Jonathan H. Esensten et al. IMMUNITY
- Perspectives of ofatumumab as CD20 targeted therapy in rheumatoid arthritis and other autoimmune diseases
- (2016) Yves Marie Pers et al. Immunotherapy
- Lymphocyte-activation gene 3 + (LAG3 + ) forkhead box protein 3 − (FOXP3 − ) regulatory T cells induced by B cells alleviates joint inflammation in collagen-induced arthritis
- (2016) Szu-Ying Chen et al. JOURNAL OF AUTOIMMUNITY
- Tolerogenic dendritic cells
- (2016) Maisa C. Takenaka et al. Seminars in Immunopathology
- Novel Foxp3− IL-10− Regulatory T-cells Induced by B-Cells Alleviate Intestinal Inflammation in Vivo
- (2016) Tzu-Yu Shao et al. Scientific Reports
- The Proportion of Regulatory T Cells in Patients with Rheumatoid Arthritis: A Meta-Analysis
- (2016) Takayoshi Morita et al. PLoS One
- The role of the Th17 cytokines IL-17 and IL-22 in Rheumatoid Arthritis pathogenesis and developments in cytokine immunotherapy
- (2015) Debbie M. Roeleveld et al. CYTOKINE
- Altered Immunoregulation in Rheumatoid Arthritis: The Role of Regulatory T Cells and Proinflammatory Th17 Cells and Therapeutic Implications
- (2015) Alessia Alunno et al. MEDIATORS OF INFLAMMATION
- Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis
- (2015) Michael Bonelli et al. RHEUMATOLOGY
- The Efficacy of Abatacept in Reducing Synovial T Cell Activation by CD1c Myeloid Dendritic Cells Is Overruled by the Stimulatory Effects of T Cell-Activating Cytokines
- (2015) F. M. Moret et al. Arthritis & Rheumatology
- Methotrexate Restores Regulatory T Cell Function Through Demethylation of the FoxP3 Upstream Enhancer in Patients With Rheumatoid Arthritis
- (2015) Adam P. Cribbs et al. Arthritis & Rheumatology
- Abatacept (cytotoxic T lymphocyte antigen 4-immunoglobulin) improves B cell function and regulatory T cell inhibitory capacity in rheumatoid arthritis patients non-responding to anti-tumour necrosis factor-α agents
- (2014) A. Picchianti Diamanti et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Decreased expression of microRNA-21 correlates with the imbalance of Th17 and Treg cells in patients with rheumatoid arthritis
- (2014) Liyang Dong et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- CTLA4-Ig (abatacept) therapy modulates T cell effector functions in autoantibody-positive rheumatoid arthritis patients
- (2013) Jennifer Pieper et al. BMC IMMUNOLOGY
- CTLA4Ig Inhibits Effector T Cells through Regulatory T Cells and TGF-
- (2013) C. M. Deppong et al. JOURNAL OF IMMUNOLOGY
- Interaction of HLA-DRB1*09:01 and *04:05 with Smoking Suggests Distinctive Mechanisms of Rheumatoid Arthritis Susceptibility Beyond the Shared Epitope
- (2013) S.-Y. Bang et al. JOURNAL OF RHEUMATOLOGY
- Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells
- (2013) Nicola Gagliani et al. NATURE MEDICINE
- Brief Report: Inhibition of interleukin-6 function corrects Th17/Treg cell imbalance in patients with rheumatoid arthritis
- (2012) Maxime Samson et al. ARTHRITIS AND RHEUMATISM
- Abatacept (CTLA-4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis
- (2012) M. Bonelli et al. ARTHRITIS AND RHEUMATISM
- Regulatory Aspects of New Medicines Targeted at Treatment of Autoimmune Diseases
- (2012) K M Hull et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- CTLA-4-Ig Therapy Diminishes the Frequency but Enhances the Function of Treg Cells in Patients with Rheumatoid Arthritis
- (2011) Crisol Álvarez-Quiroga et al. JOURNAL OF CLINICAL IMMUNOLOGY
- The Pathogenesis of Rheumatoid Arthritis
- (2011) Iain B. McInnes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Trans-Endocytosis of CD80 and CD86: A Molecular Basis for the Cell-Extrinsic Function of CTLA-4
- (2011) O. S. Qureshi et al. SCIENCE
- Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial)
- (2009) P. Emery et al. ANNALS OF THE RHEUMATIC DISEASES
- Epitope-specific immunotherapy of rheumatoid arthritis: Clinical responsiveness occurs with immune deviation and relies on the expression of a cluster of molecules associated with T cell tolerance in a double-blind, placebo-controlled, pilot phase II trial
- (2009) Eva C. Koffeman et al. ARTHRITIS AND RHEUMATISM
- New approaches of B-cell-directed therapy: beyond rituximab
- (2009) Thomas Dörner et al. CURRENT OPINION IN RHEUMATOLOGY
- TGF-β: A Master of All T Cell Trades
- (2008) Ming O. Li et al. CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started